Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
Mid-size biotechs making their way
Boston Globe, MA
Sun, 10/23/11 - 11:56 am
Vertex Pharmaceuticals
Ariad Pharmaceuticals
Ironwood
Curis
8 Biotech Stocks Seeing Bearish Options Sentiment
Seeking Alpha
Wed, 10/12/11 - 10:42 am
Acorda
Cytori
Indenix
Vical
Medivation
Optimer Pharmaceuticals
Vertex Pharmaceuticals
XenoPort
This Week in Biotech
Motley Fool
Sat, 10/1/11 - 01:51 pm
Pharmasset
GSK
Human Genome Sciences
Vertex Pharmaceuticals
Optimer Pharmaceuticals
Cubist Pharmaceuticals
Array Biopharma
AstraZeneca
7 Possible Biotech Takeover Targets
Seeking Alpha
Sun, 09/18/11 - 12:02 pm
Human Genome Sciences
Vertex Pharmaceuticals
Lexicon Pharmaceuticals
Amarin
Exelixis
Dendreon
Acorda Therapeutics
Vertex Pharma receives Canadian OK for Incivek
Yahoo/AP
Mon, 08/22/11 - 11:50 am
Vertex Pharmaceuticals
Canada
Incivek
hepatitis C
Could Vertex Sell $1 Billion Of Its Hepatitis C Drug This Year?
Forbes
Fri, 08/19/11 - 10:58 am
Vertex Pharmaceuticals
hepatitis C
Incivek
3 biotech stocks battle the ‘Dendreon Effect’ - Company’s troubles with Provenge chill fellow drug makers
Marketwatch
Fri, 08/19/11 - 09:20 am
Dendreon
Provenge
Savient
Human Genome Sciences
Vertex Pharmaceuticals
InterMune
Seattle Genetics
Warning: Vertex Pharmaceuticals May Be Hiding Weakness
Motley Fool
Mon, 08/15/11 - 10:07 am
Vertex Pharmaceuticals
What Happened to U.S. Pharma?
Motley Fool
Sat, 08/13/11 - 02:59 pm
JNJ
Bristol-Myers Squibb
Eli Lilly
Merck
Vertex Pharmaceuticals
Pfizer
Mead Johnson
Good Biotech Stocks for a Bear Market
TheStreet.com
Tue, 08/9/11 - 01:27 pm
Elan
Targacept
Dendreon
Gilead Sciences
Sequenom
Vertex Pharmaceuticals
Amgen
Alexion
Biogen Idec
Celgene
Still Want to Be the Next Dendreon?
Motley Fool
Sat, 08/6/11 - 01:01 pm
Dendreon
Vertex Pharmaceuticals
Incivek
hepatitis B
Does Vertex Pharmaceuticals Deserve a Higher Valuation?
Seeking Alpha
Wed, 08/3/11 - 11:05 am
Vertex Pharmaceuticals
Merck: Don't declare a hep C victor yet
Fierce Pharma
Tue, 08/2/11 - 12:40 pm
Merck
Vertex Pharmaceuticals
Incivek
hepatitis C
Victrelis
Vertex Pharmaceuticals Beats Merck in Hepatitis C Drug Sales
Bloomberg
Sat, 07/30/11 - 09:51 am
Vertex Pharmaceuticals
Merck
Incivek
Victrelis
hepatitis C
Vertex advances 8% on earnings, upgrade
MarketWatch
Sat, 07/30/11 - 09:44 am
Vertex Pharmaceuticals
Vertex Earnings: $75M in Incivek Sales
TheStreet.com
Thu, 07/28/11 - 06:05 pm
earnings
Vertex Pharmaceuticals
Vertex 4-drug hepatitis C combo shows promise
Reuters
Wed, 07/27/11 - 10:40 am
Vertex Pharmaceuticals
hepatitis C
VX-222
Incivek
pegylated interferon
ribaviron
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Human Genome Sciences
Vertex Pharmaceuticals
Acorda Therapeutics
Dendreon
Avanir
lupus
Benlysta
Incivek
hepatitis C
MS
AMPYRA
Provenge
prostate cancer
Nuedexta
PBA
The 15 Most-Watched BioPharma Stocks
Motley Fool
Wed, 07/13/11 - 04:53 pm
MannKind
Celgene
Amarin
Vertex Pharmaceuticals
BioSante
Keryx
Amylin
Regeneron
Immunogen
Cubist Pharmaceuticals
Isis Pharmaceuticals
Sunesis
OPKO Health
SciClone
Cephalon
J&J Has to Resolve Hepatitis C Drug Conflict, Medivir CEO Says
Bloomberg
Wed, 07/13/11 - 08:23 am
Medivir
JNJ
hepatitis C
Incivek
Tibotec
TMC435
Vertex Pharmaceuticals
Pages
« first
‹ previous
…
23
24
25
26
27
28
29
30
31
…
next ›
last »